Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
$0.25
+4.1%
$0.77
$0.22
$2.79
$2.79M0.98161,098 shs11,072 shs
Positron Co. stock logo
POSC
Positron
$1.15
-8.0%
$1.27
$0.87
$1.97
$29.82M0.985,171 shs779 shs
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
$37.89
+1.5%
$43.29
$3.16
$53.82
$1.27B-1.56299,033 shs138,607 shs
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
$1.04
-2.8%
$1.24
$0.99
$23.79
$1.53M2.88101,689 shs13,979 shs
Vaso Co. stock logo
VASO
Vaso
$0.28
+1.5%
$0.29
$0.19
$0.37
$52.72M2.03120,243 shs19,150 shs
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
-6.69%+3.90%-74.93%-76.23%-85.12%
Positron Co. stock logo
POSC
Positron
0.00%+8.70%-0.51%0.00%-12.59%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-5.08%+0.51%-13.56%-19.87%+972.99%
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
-3.60%-7.76%-10.83%-20.15%-92.13%
Vaso Co. stock logo
VASO
Vaso
-0.04%-6.58%-6.70%-2.02%+16.63%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/AN/AN/AN/AN/AN/AN/AN/A
Positron Co. stock logo
POSC
Positron
N/AN/AN/AN/AN/AN/AN/AN/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
3.9175 of 5 stars
3.50.00.04.61.34.20.6
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
N/AN/AN/AN/AN/AN/AN/AN/A
Vaso Co. stock logo
VASO
Vaso
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/AN/AN/AN/A
Positron Co. stock logo
POSC
Positron
N/AN/AN/AN/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
3.00
Buy$55.6046.74% Upside
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
N/AN/AN/AN/A
Vaso Co. stock logo
VASO
Vaso
N/AN/AN/AN/A

Current Analyst Ratings

Latest NDRA, SLNO, POSC, TIVC, and VASO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
2/5/2024
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$93.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/AN/AN/AN/A$0.67 per shareN/A
Positron Co. stock logo
POSC
Positron
$740K40.30N/AN/A($0.04) per share-28.75
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/AN/AN/AN/A$5.16 per shareN/A
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
$1.18M1.30N/AN/A$2.44 per share0.43
Vaso Co. stock logo
VASO
Vaso
$81.02M0.65$0.03 per share8.64$0.14 per share2.03

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
-$10.06M-$1.93N/AN/AN/A-197.36%-144.22%5/20/2024 (Estimated)
Positron Co. stock logo
POSC
Positron
-$1.64MN/A0.00N/A-222.99%N/A-65.25%N/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-$38.99M-$2.97N/AN/AN/AN/A-79.65%-52.92%5/14/2024 (Estimated)
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
-$8.24M-$42.48N/AN/A-701.02%-186.19%-138.20%5/20/2024 (Estimated)
Vaso Co. stock logo
VASO
Vaso
$4.80M$0.039.47N/A5.93%19.02%6.59%5/13/2024 (Estimated)

Latest NDRA, SLNO, POSC, TIVC, and VASO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/1/2024Q4 2023
Vaso Co. stock logo
VASO
Vaso
N/A$0.01+$0.01$0.01N/A$21.92 million
3/28/2024Q4 2023
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/A-$0.17-$0.17-$0.17N/AN/A
3/6/2024Q4 2023
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-$0.31-$0.33-$0.02-$0.33N/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/AN/AN/AN/AN/A
Positron Co. stock logo
POSC
Positron
N/AN/AN/AN/AN/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/AN/AN/AN/AN/A
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
N/AN/AN/AN/AN/A
Vaso Co. stock logo
VASO
Vaso
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/A
6.26
3.36
Positron Co. stock logo
POSC
Positron
N/A
0.70
0.06
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/A
14.89
14.89
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
N/A
3.32
2.78
Vaso Co. stock logo
VASO
Vaso
N/A
1.50
1.45

Ownership

Institutional Ownership

CompanyInstitutional Ownership
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
1.19%
Positron Co. stock logo
POSC
Positron
N/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
97.42%
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
4.25%
Vaso Co. stock logo
VASO
Vaso
N/A

Insider Ownership

CompanyInsider Ownership
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
4.80%
Positron Co. stock logo
POSC
Positron
17.20%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
23.70%
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
2.70%
Vaso Co. stock logo
VASO
Vaso
44.56%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
2111.04 million10.51 millionNot Optionable
Positron Co. stock logo
POSC
Positron
1925.93 million21.47 millionNot Optionable
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
3333.41 million25.49 millionOptionable
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
91.47 million1.43 millionNot Optionable
Vaso Co. stock logo
VASO
Vaso
300185.63 million102.91 millionNot Optionable

NDRA, SLNO, POSC, TIVC, and VASO Headlines

SourceHeadline
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of bluebird bioSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of bluebird bio
markets.businessinsider.com - April 26 at 8:11 AM
Exa-Cel Eliminates Vaso-Occlusive Crises in Most Sickle Cell PatientsExa-Cel Eliminates Vaso-Occlusive Crises in Most Sickle Cell Patients
physiciansweekly.com - April 26 at 3:09 AM
Justice department to pay 700K to estate of Charleston man who died in federal prisonJustice department to pay 700K to estate of Charleston man who died in federal prison
msn.com - April 25 at 10:08 PM
CASGEVY gene therapy eliminates vaso-occlusive crises in sickle cell patientsCASGEVY gene therapy eliminates vaso-occlusive crises in sickle cell patients
news-medical.net - April 25 at 12:04 PM
How can I cut down on food waste?How can I cut down on food waste?
unr.edu - April 24 at 3:27 PM
Greek lawmaker faces criminal charges after brawl in parliamentGreek lawmaker faces criminal charges after brawl in parliament
politico.eu - April 24 at 3:27 PM
Alteration of brain network condition could predict painful vaso-occlusive crisis in patients with sickle cell diseaseAlteration of brain network condition could predict painful vaso-occlusive crisis in patients with sickle cell disease
medicalxpress.com - April 24 at 3:27 PM
Greece arrests suspected members of criminal group linked to sports violenceGreece arrests suspected members of criminal group linked to sports violence
devdiscourse.com - April 23 at 3:26 PM
Greek police arrest 63 people in football hooligan crackdown after string of murdersGreek police arrest 63 people in football hooligan crackdown after string of murders
independent.co.uk - April 23 at 3:26 PM
Profluent combines LLMs and CRISPR for open-source gene editing projectProfluent combines LLMs and CRISPR for open-source gene editing project
fiercebiotech.com - April 23 at 3:26 PM
Innovative Chef Takes Over INNSiDE Hotels LUZ Bangkok Tapas BarInnovative Chef 'Takes Over' INNSiDE Hotel's LUZ Bangkok Tapas Bar
newswit.com - April 23 at 9:58 AM
Maryland represented well in 2024 NFL draft class, including several from BaltimoreMaryland represented well in 2024 NFL draft class, including several from Baltimore
wbaltv.com - April 22 at 2:34 PM
Cobra, the Brewery-District cocktail bar and restaurant, honored as one of regions bestCobra, the Brewery-District cocktail bar and restaurant, honored as one of region's best
msn.com - April 21 at 9:13 AM
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BlueSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue
markets.businessinsider.com - April 21 at 9:13 AM
Sickle Cell and Hearing LossSickle Cell and Hearing Loss
msn.com - April 20 at 12:29 AM
The 10 most valuable MLS players in 2024 according to TransfermarktThe 10 most valuable MLS players in 2024 according to Transfermarkt
msn.com - April 19 at 2:28 PM
Vaso (OTCMKTS:VASO) Stock Passes Above 200 Day Moving Average of $0.29Vaso (OTCMKTS:VASO) Stock Passes Above 200 Day Moving Average of $0.29
americanbankingnews.com - April 19 at 3:40 AM
Todo aquello que nos quisieron enseñar las canciones de DisneyTodo aquello que nos quisieron enseñar las canciones de Disney
hercampus.com - April 18 at 10:43 AM
Unity Biotechnology gets grant for senolytic agents for treating age-related eye conditionsUnity Biotechnology gets grant for senolytic agents for treating age-related eye conditions
pharmaceutical-technology.com - April 17 at 1:30 PM
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of bluebird bioDEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of bluebird bio
markets.businessinsider.com - April 16 at 11:07 PM
One bold initiative to recruit Mexican doctors to help bridge language barriers back homeOne bold initiative to recruit Mexican doctors to help bridge language barriers back home
whyy.org - April 15 at 12:04 PM
Interior ministry confirms European Parliament and local government elections for June 9Interior ministry confirms European Parliament and local government elections for June 9
msn.com - April 13 at 1:40 AM
Sun shines on Imbros’ Anzac connection in SydneySun shines on Imbros’ Anzac connection in Sydney
neoskosmos.com - April 12 at 8:40 PM
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BlueSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue
markets.businessinsider.com - April 10 at 8:15 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

ENDRA Life Sciences logo

ENDRA Life Sciences

NASDAQ:NDRA
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Positron logo

Positron

OTCMKTS:POSC
Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York.
Soleno Therapeutics logo

Soleno Therapeutics

NASDAQ:SLNO
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.
Tivic Health Systems logo

Tivic Health Systems

NASDAQ:TIVC
Tivic Health Systems Inc. operates as a health technology company, focuses on developing and commercializing non-invasive bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal congestion pains. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
Vaso logo

Vaso

OTCMKTS:VASO
Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.